Results 231 to 240 of about 51,767 (241)

Evaluation of the Effect of IL‐1 Antagonists on Pituitary Function

International Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease frequently observed in populations along the Eastern Mediterranean coast, characterized by recurrent fever, abdominal pain, and joint inflammation. The disease results from mutations in the MEFV gene, which plays a critical role in regulating IL‐1β secretion ...
Fadime Aktas Koc, Baris Sariakcali, Ali Sahin, Vikas Kumar Roy   +3 more
wiley   +1 more source

Correction to: Isolated AL Amyloidosis of the Colon: A Rare Presentation. [PDF]

ACG Case Rep J
Garcia A, Qureshi M, Dhawan I, Rafferty W, Budak-Alpdogan T, Giordano S.   +5 more
europepmc   +1 more source

Piecing together the intricate puzzle of organ recovery in AL amyloidosis. [PDF]

Br J Haematol
Nuvolone M, Palladini G.
europepmc   +1 more source

Between Charybdis and Scylla-an Odyssey in AL amyloidosis: insights and learnings from a narrative review and case report series. [PDF]

Ther Adv Hematol
Sabbour H, Alhuraiji A, Hanbali A, Khan F, Alameri J, Alzaher S, Mohty D, Palladini G.   +7 more
europepmc   +1 more source

Febrile neutropenia in patients with Duffy-null-associated neutrophil counts and multiple myeloma or AL amyloidosis. [PDF]

Blood Adv
Abdallah M, Arters F, Patel J, Edwards C, Lerner A, Petrocca F, Dockerty M, Fuller B, Godfrey A, Staron A, Sanchorawala V, Sloan JM, Bertrand K, Szalat R.   +13 more
europepmc   +1 more source

Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis. [PDF]

Pharmaceuticals (Basel)
Morgan GJ, Yung Z, Spencer BH, Sanchorawala V, Prokaeva T.   +4 more
europepmc   +1 more source

Defying the odds: 30 years in AL amyloidosis research-recent barriers to clinical trial enrollment. [PDF]

Blood Adv
Sanchorawala V, Barroso B, Shelton A, Goetz E, Mendelson L, Joshi T, Burke N, Sloan JM, Staron A.   +8 more
europepmc   +1 more source

The features of cardiomyopathy in AL and ATTR amyloidosis

B. Ponomarev, Kamilla R. Pashayeva, Narmina Yu. Feyziyeva, С Г Раденска-Лоповок   +3 more
openalex   +2 more sources

Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis.

JAMA Cardiol
Porcari A, Masi A, Martinez-Naharro A, Razvi Y, Patel R, Ioannou A, Rauf MU, Sinigiani G, Wisniowski B, Filisetti S, Currie-Cathey J, O'Beara S, Kotecha T, Knight D, Moon JC, Sinagra G, Virsinskaite R, Gilbertson J, Venneri L, Petrie A, Lachmann H, Whelan C, Kellman P, Ravichandran S, Cohen O, Mahmood S, Manisty C, Hawkins PN, Gillmore JD, Wechalekar AD, Fontana M.   +30 more
europepmc   +1 more source